Yahoo Web Search

  1. Company News For Oct 3, 2019

    Zacks via Yahoo FinanceOct 03 14:18 PM

    Savara Inc. 's SVRA share dropped 58.5% after the company announced that the U.S. Food and Drug Administration has reported its application for new medication to be insufficient

  2. Brexit-Backing Hedge Fund Boss Odey Rejects Conflict Claims

    Bloomberg via Yahoo FinanceOct 01 7:30 AM

    Former Chancellor of the Exchequer Philip Hammond and Boris Johnson’s sister, Rachel, have said recently that “speculators” among the prime minister’s financial backers stand to make ...

  3. NASDAQ: GILD) Type of Application: sNDA Candidate: Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets) Indication: Pre-exposure prophylaxis, or PrEP, for HIV-1 infection Date ...

  4. PRESS DIGEST- Wall Street Journal - Oct. 1

    Reuters via Yahoo FinanceOct 01 5:43 AM

    s president, a senior State Department official said Monday, a disclosure that ties the State Department more closely to the House impeachment inquiry. - Endo International Plc, Johnson ...

  5. Abiomed's (ABMD) Impella 5.5 With SmartAssist Gets FDA Nod

    Zacks via Yahoo FinanceOct 02 13:25 PM

    Abiomed, Inc.’s ABMD newest heart pump, the Impella 5.5 with SmartAssist, recently received FDA pre-market approval based on its safety and efficacy in the therapy of cardiogenic shock ...

  6. Here is How Hedge Funds’ Most Popular Stock Performed in Q3

    Insider Monkey via Yahoo FinanceOct 01 17:59 PM

    One of their top picks is Facebook Inc (NASDAQ:FB), so let’s take a closer look at the sentiment that surrounds it in the current quarter. Facebook Inc (NASDAQ:FB) shareholders ...

  7. What do these smart investors think about Berkshire Hathaway Inc. (NYSE:BRK-B)? Is Berkshire Hathaway Inc. (NYSE:BRK-B) a great stock to buy now? Hedge funds are becoming more ...

  8. NASDAQ: AMGN)'s Forteo, and Australian biotech Clinuvel Pharmaceuticals Ltd (OTC: CLVLY)'s Scenesse to treat erythropoietic protoporphyria was also given the go-ahead by the regulatory agency ...

  9. The following is a roundup of top developments in the biotech space over the last 24 hours. Biotech stocks that hit 52-week highs Sept. AstraZeneca plc (NYSE: AZN) GlaxoSmithKline plc (NYSE: ...

  10. NASDAQ: ABMD) Adamas Pharmaceuticals Inc (NASDAQ: ADMS) Adamis Pharmaceuticals Corp (NASDAQ: ADMP) Adaptive Biotechnologies Corp (NASDAQ: ADPT) Aduro BioTech Inc (NASDAQ: ADRO) ...

  1. Ads
    related to Johnson & Johnson Inc